Furthermore, higher expression of SphK1 in HCC cell lines mediates resistance to oxaliplatin via modulating Akt/GSK3β pathway, while SphK1 knockdown increases chemosensitivity of HCC cell lines [72]. This evidence concerns the gene GSK3B and hepatocellular carcinoma.